Stella Diagnostics Inc. (SLDX)
USD 0.05
(13.69%)
USD 0.05
(13.69%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.42 Million USD | 366.48% |
| 2022 | 2.44 Million USD | -48.32% |
| 2021 | 4.74 Million USD | 2775.42% |
| 2020 | 164.84 Thousand USD | -80.03% |
| 2019 | 825.47 Thousand USD | -6.55% |
| 2018 | 883.29 Thousand USD | 16299.85% |
| 2017 | 5386.00 USD | 0.0% |
| 2015 | 44 Thousand USD | -77.63% |
| 2014 | 196.72 Thousand USD | 78442.43% |
| 2013 | 250.47 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 192.29 Thousand USD | -11.83% |
| 2024 Q1 | 218.09 Thousand USD | -85.42% |
| 2023 Q4 | 1.49 Million USD | 278.35% |
| 2023 FY | 11.42 Million USD | 366.48% |
| 2023 Q1 | 9.33 Million USD | 1045.51% |
| 2023 Q2 | 204.36 Thousand USD | -97.81% |
| 2023 Q3 | 395.23 Thousand USD | 93.4% |
| 2022 Q2 | 370.72 Thousand USD | -60.69% |
| 2022 FY | 2.44 Million USD | -48.32% |
| 2022 Q4 | 814.65 Thousand USD | 62.07% |
| 2022 Q3 | 502.64 Thousand USD | 35.58% |
| 2022 Q1 | 942.99 Thousand USD | 0.0% |
| 2021 Q2 | 440.64 Thousand USD | 0.0% |
| 2021 Q3 | 185.84 Thousand USD | -57.82% |
| 2021 FY | 4.74 Million USD | 2775.42% |
| 2020 Q3 | 43.31 Thousand USD | -94.51% |
| 2020 FY | 164.84 Thousand USD | -80.03% |
| 2020 Q1 | 3089.00 USD | 0.0% |
| 2020 Q2 | 788.5 Thousand USD | 25426.25% |
| 2019 FY | 825.47 Thousand USD | -6.55% |
| 2018 FY | 883.29 Thousand USD | 16299.85% |
| 2018 Q1 | 220.15 Thousand USD | 0.0% |
| 2017 FY | 5386.00 USD | 0.0% |
| 2015 FY | 44 Thousand USD | -77.63% |
| 2014 FY | 196.72 Thousand USD | 78442.43% |
| 2013 FY | 250.47 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -989.318% |
| Arrayit Corporation | 6.19 Million USD | -84.378% |
| Atlantic International Corp. | 5.57 Million USD | -104.847% |
| Biocept, Inc. | 29.4 Million USD | 61.134% |
| Bioqual, Inc. | 7.44 Million USD | -53.407% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -1379.903% |
| DermTech, Inc. | 104.01 Million USD | 89.014% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 93.137% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 49.491% |
| iMD Companies, Inc. | 151.8 Thousand USD | -7427.189% |
| IDenta Corp. | 662.97 Thousand USD | -1623.587% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 43.52% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -29289.548% |
| InVitro International | 661.32 Thousand USD | -1627.89% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -60.988% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -19563.667% |
| Medical Imaging Corp. | 1.91 Million USD | -497.593% |
| NovelStem International Corp. | 3.53 Million USD | -222.996% |
| Optigenex Inc. | 1.28 Million USD | -787.276% |
| PharmChem, Inc. | 2.93 Million USD | -289.835% |
| Proteome Sciences plc | 3.26 Million USD | -249.662% |
| Response Genetics, Inc | 25.31 Million USD | 54.868% |
| Rennova Health, Inc. | 7.67 Million USD | -48.831% |
| RushNet, Inc. | 1.78 Million USD | -538.62% |
| ScreenPro Security Inc. | 3.23 Million USD | -252.802% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -55.617% |
| Todos Medical Ltd. | 14.05 Million USD | 18.716% |